Biosynthesis of cardiac natriuretic peptides

Results and Problems in Cell Differentiation

Volumn 50, Issue , 2010, Pages 97-120

  Goetze, Jens Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NATRIURETIC FACTOR; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; CAT; CHEMISTRY; DOG; GENE EXPRESSION REGULATION; HEART MUSCLE CELL; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; PROTEIN PROCESSING; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; CATS; DNA, COMPLEMENTARY; DOGS; GENE EXPRESSION REGULATION; HUMANS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDES; PEPTIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 77950280653     PISSN: 00801844     EISSN: 18610412     Source Type: Book Series    
DOI: 10.1007/400_2009_25     Document Type: Article

References (148)

1. Aburaya M, Hino J, Minamino N et al (1989) Isolation and identification of rat brain natriuretic peptides in cardiac atrium. Biochem Biophys Res Commun 163:226-232
2. Ahrén B (2007) DPP-4 inhibitors. Best Pract Res Clin Endocrinol Metab 21:517-533
3. Arden KC, Viars CS, Weiss S et al (1995) Localization of the human B-type natriuretic peptide precursor (NPPB) gene to chromosome 1p36. Genomics 26:385-389
4. Asano K, Murakami M, Endo D et al (1999) Complementary DNA cloning, tissue distribution, and synthesis of canine brain natriuretic peptide. Am J Vet Res 60:860-864
5. Azfer A, Niu J, Rogers LM et al (2006) Activation of endoplasmic reticulum stress response during the development of ischemic heart disease. Am J Physiol Heart Circ Physiol 291: H1411-H1420
6. Baertschi AJ, Monnier D, Schmidt U et al (2001) Acid prohormone sequence determines size, shape, and docking of secretory vesicles in atrial myocytes. Circ Res 89:e23-e29
7. Baxter GF (2004) The natriuretic peptides: an introduction. Basic Res Cardiol 99:71-75
8. Bayliss WM, Starling EH (1902) The mechanism of pancreatic secretion. J Physiol 28:325-353
9. Beaubien G, Schafer MK, Weihe E et al (1995) The distinct gene expression of the pro-hormone convertases in the rat heart suggests potential substrates. Cell Tissue Res 279:539-549
10. Bloomquist BT, Eipper BA, Mains RE (1991) Prohormone-converting enzymes: regulation and evaluation of function using antisense RNA. Mol Endocrinol 5:2014-2024
11. Brandt I, Lambeir AM, Ketelslegers JM et al (2006) Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form. Clin Chem 52:82-87
12. Buckley MG, Sagnella GA, Markandu ND et al (1990) Concentrations of N-terminal ProANP in human plasma: evidence for ProANP (1-98) as the circulating form. Clin Chim Acta 191:1-14
13. Burnett JC Jr, Kao PC, Hu DC et al (1986) Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231:1145-1147
14. Canaff L, Brechler V, Reudelhuber TL et al (1996) Secretory granule targeting of atrial natriuretic peptide correlates with its calcium-mediated aggregation. Proc Natl Acad Sci USA 93:9483-9487
15. Casco VH, Veinot JP, Kuroski de Bold ML et al (2002) Natriuretic peptide system gene expression in human coronary arteries. J Histochem Cytochem 50:799-809
16. Chiravuri M, Agarraberes F, Mathieu SL et al (2000) Vesicular localization and characterization of a novel post-proline-cleaving aminodipeptidase, quiescent cell proline dipeptidase. J Immunol 165:5695-5702
17. Christoffersen C, Goetze JP, Bartels ED et al (2002) Chamber-dependent expression of brain natriuretic peptide and its mRNA in normal and diabetic pig heart. Hypertension 40:54-60
18. Christoffersen C, Hunter I, Jensen AL et al (2007) Diabetes and the endocrine heart. Eur Heart J 28:2427-2429
19. Chun YS, Hyun JY, Kwak YG et al (2003) Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1. Biochem J 370: 149-157
20. Clerico A, Emdin M (2004) Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 50:33-50
21. Corti R, Burnett JC Jr, Rouleau JL et al (2001) Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease? Circulation 104:1856-1862
22. Costello-Boerrigter LC, Burnett JC Jr (2005) The prognostic value of N-terminal proB-type natriuretic peptide. Nat Clin Pract Cardiovasc Med 2:194-201
23. Cowie MR, Jourdain P, Maisel A et al (2003) Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24:1710-1718
24. Crimmins DL, Kao JL (2008) A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein. Arch Biochem Biophys 475:36-41
25. Daniels LB, Maisel AS (2007) Natriuretic peptides. J Am Coll Cardiol 50:2357-2368
26. Daughaday WH, Trivedi B, Baxter RC (1993) Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proc Natl Acad Sci USA 90:5823-5827
27. de Bold AJ (2007) Determinants of brain natriuretic peptide gene expression and secretion in acute cardiac allograft rejection. Curr Opin Cardiol 22:146-150
28. de Bold AJ, Flynn TG (1983) Cardionatrin I - a novel heart peptide with potent diuretic and natriuretic properties. Life Sci 33:297-302
29. de Bold AJ, Borenstein HB, Veress AT et al (1981) A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 28:89-94
30. de Lemos JA, McGuire DK, Drazner MH (2003) B-type natriuretic peptide in cardiovascular disease. Lancet 362:316-322
31. Dickey DM, Burnett JC Jr, Potter LR (2008) Novel bifunctional natriuretic peptides as potential therapeutics. J Biol Chem 283(50):35003-35009 Epub 2008 Oct 21
32. Doyama K, Fukumoto M, Takemura G et al (1998) Expression and distribution of brain natriuretic peptide in human right atria. J Am Coll Cardiol 32:1832-1838
33. Dries DL, Victor RG, Rame JE et al (2005) Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension. Circulation 112:2403-2410
34. Dschietzig T, Richter C, Bartsch C et al (2001) The pregnancy hormone relaxin is a player in human heart failure. FASEB J 15:2187-2195
35. Eipper BA, May V, Braas KM (1988) Membrane-associated peptidylglycine alpha-amidating monooxygenase in the heart. J Biol Chem 263:8371-8379
36. Flynn TG, de Bold ML, de Bold AJ (1983) The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties. Biochem Biophys Res Commun 117:859-865
37. Flynn TG, Brar A, Tremblay L et al (1989) Isolation and characterization of iso-rANP, a new natriuretic peptide from rat atria. Biochem Biophys Res Commun 161:830-837
38. Gardner DG, Chen S, Glenn DJ et al (2007) Molecular biology of the natriuretic peptide system: implications for physiology and hypertension. Hypertension 49:419-426
39. Giuliani I, Rieunier F, Larue C et al (2006) Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem 52:1054-1061
40. Goetze JP (2004) Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited. Clin Chem 50:1503-1510
41. Goetze JP, Kastrup J, Pedersen F et al (2002) Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing. Clin Chem 48:1035-1042
42. Goetze JP, Kastrup J, Rehfeld JF (2003) The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure? Eur Heart J 24: 1471-1472
43. Goetze JP, Yongzhong W, Rehfeld JF et al (2004) Coronary angiography transiently increases plasma pro-B-type natriuretic peptide. Eur Heart J 25:759-764
44. Goetze JP, Rehfeld JF, Videbaek R et al (2005) B-type natriuretic peptide and its precursor in cardiac venous blood from failing hearts. Eur J Heart Fail 7:69-74
45. Goetze JP, Friis-Hansen L, Rehfeld JF et al (2006) Atrial secretion of B-type natriuretic peptide. Eur Heart J 27:1648-1650
46. Hanford DS, Glembotski CC (1996) Stabilization of the B-type natriuretic peptide mRNA in cardiac myocytes by alpha-adrenergic receptor activation: potential roles for protein kinase C and mitogen-activated protein kinase. Mol Endocrinol 10:1719-1727
47. Hanford DS, Thuerauf DJ, Murray SF et al (1994) Brain natriuretic peptide is induced by alpha 1-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes. J Biol Chem 269:26227-26233
48. Hasegawa K, Fujiwara H, Itoh H et al (1991) Light and electron microscopic localization of brain natriuretic peptide in relation to atrial natriuretic peptide in porcine atrium. Immunohistocytochemical study using specific monoclonal antibodies. Circulation 84:1203-1209
49. Hasegawa K, Fujiwara H, Doyama K et al (1993) Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies. Am J Pathol 142:107-116
50. Hawkridge AM, Heublein DM, Bergen HR III et al (2005) Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad Sci USA 102:17442-17447
51. Hawkridge AM, Muddiman DC, Hebulein DM et al (2008) Effect of plasma protein depletion on BNP-32 recovery. Clin Chem 54:933-934
52. Heidrich FM, Zhang K, Estrada M et al (2008) Chromogranin B regulates calcium signaling, nuclear factor kappaB activity, and brain natriuretic peptide production in cardiomyocytes. Circ Res 102:1230-1238
53. Hendy GN, Li T, Girard M et al (2006) Targeted ablation of the chromogranin a (Chga) gene: normal neuroendocrine dense-core secretory granules and increased expression of other granins. Mol Endocrinol 20:1935-1947
54. Henriksen JH, Goetze JP, Fuglsang S et al (2003) Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut 52:1511-1517
55. Hino J, Tateyama H, Minamino N et al (1990) Isolation and identification of human brain natriuretic peptides in cardiac atrium. Biochem Biophys Res Commun 167:693-700
56. Hodgson-Zingman DM, Karst ML, Zingman LV et al (2008) Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation. N Engl J Med 359:158-165
57. Holst JJ (2004) On the physiology of GIP and GLP-1. Horm Metab Res 36:747-754
58. Hooper JD, Scarman AL, Clarke BE et al (2000) Localization of the mosaic transmembrane serine protease corin to heart myocytes. Eur J Biochem 267:6931-6937
59. Hunt PJ, Yandle TG, Nicholls MG et al (1995) The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 214:1175-1183
60. Hunt PJ, Espiner EA, Nicholls MG et al (1997a) The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32. Peptides 18:1475-1481
61. Hunt PJ, Richards AM, Nicholls MG et al (1997b) Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment. Clin Endocrinol 47:287-296
62. Inoue K, Naruse K, Yamagami S et al (2003) Four functionally distinct C-type natriuretic peptides found in fish reveal evolutionary history of the natriuretic peptide system. Proc Natl Acad Sci USA 100:10079-10084
63. Jamieson JD, Palade GE (1964) Specific granules in atrial muscle cells. J Cell Biol 23:151-172
64. Januzzi JL Jr, Chen-Tournoux AA, Moe G (2008) Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Am J Cardiol 101:29-38
65. Jin H, Fedorowicz G, Yang R et al (2004) Thyrotropin-releasing hormone is induced in the left ventricle of rats with heart failure and can provide inotropic support to the failing heart. Circulation 109:2240-2245
66. John SW, Krege JH, Oliver PM et al (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679-681
67. Kambayashi Y, Nakao K, Mukoyama M et al (1990) Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett 259:341-345
68. Kisch B (1963) A significant electron microscopic difference between the atria and the ventricles of the mammalian heart. Exp Med Surg 21:193-221
69. Knappe S, Wu F, Masikat MR et al (2003) Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin. J Biol Chem 278:52363-52370
70. Kreil G (1990) Processing of precursors by dipeptidylaminopeptidases: a case of molecular ticketing. Trends Biochem Sci 15:23-26
71. Kreil G, Haiml L, Suchanek G (1980) Stepwise cleavage of the pro part of promelittin by dipeptidylpeptidase IV. Evidence for a new type of precursor-product conversion. Eur J Biochem 111:49-58
72. Kroll MH, Twomey PJ, Srisawasdi P (2007) Using the single-compartment ratio model to calculate half-life, NT-proBNP as an example. Clin Chim Acta 380:197-202
73. Kudoh S, Akazawa H, Takano H et al (2003) Stretch-modulation of second messengers: effects on cardiomyocyte ion transport. Prog Biophys Mol Biol 82:57-66
74. Labrador V, Brun C, König S et al (2004) Peptidyl-glycine alpha-amidating monooxygenase targeting and shaping of atrial secretory vesicles: inhibition by mutated N-terminal ProANP and PBA. Circ Res 95:e98-e109
75. Lam CS, Burnett JC Jr, Costello-Boerrigter L et al (2007) Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population. J Am Coll Cardiol 49:1193-1202
76. Lanfear DE (2008) Genetic variation in the natriuretic peptide system and heart failure. Heart Fail Rev (Epub ahead of print)
77. LaPointe MC (2005) Molecular regulation of the brain natriuretic peptide gene. Peptides 26:944-956
78. Liang F, Gardner DG (1999) Mechanical strain activates BNP gene transcription through a p38/ NF-kappa B-dependent mechanism. J Clin Invest 104:1603-1612
79. Liang F, O'Rear J, Schellenberger U et al (2007) Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol 49:1071-1078
80. Lisy O, Huntley BK, McCormick DJ et al (2008) Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP. J Am Coll Cardiol 52:60-68
81. Liu ZL, Wiedmeyer CE, Sisson DD et al (2002) Cloning and characterization of feline brain natriuretic peptide. Gene 292:183-190
82. Liu M, Ramos-Castañeda J, Arvan P (2003) Role of the connecting peptide in insulin biosynthesis. J Biol Chem 278:14798-14805
83. Luchner A, Stevens TL, Borgeson DD et al (1998) Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 274:H1684-H1689
84. Luckenbill KN, Christenson RH, Jaffe AS et al (2008) Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. Clin Chem 54:619-621
85. Ma KK, Ogawa T, de Bold AJ (2004) Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36:505-513
86. Mair J (2008) Biochemistry of B-type natriuretic peptide - where are we now? Clin Chem Lab Med 46:1507-1514
87. Maltese JY, Eipper BA (1992) Developmental expression of peptidylglycine alpha-amidating monooxygenase (PAM) in primary cultures of neonatal rat cardiocytes: a model for studying regulation of PAM expression in the rat heart. Mol Endocrinol 6:1998-2008
88. Marx R, Mains RE (1997) Adenovirally encoded prohormone convertase-1 functions in atrial myocyte large dense core vesicles. Endocrinology 138:5108-5118
89. McGrath MF, de Bold AJ (2005) Determinants of natriuretic peptide gene expression. Peptides 26:933-943
90. McGrath MF, de Bold ML, de Bold AJ (2005) The endocrine function of the heart. Trends Endocrinol Metab 16:469-477
91. Meirhaeghe A, Sandhu MS, McCarthy MI et al (2007) Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. Hum Mol Genet 16:1343-1350
92. Minamino N, Aburaya M, Ueda S et al (1988a) The presence of brain natriuretic peptide of 12, 000 daltons in porcine heart. Biochem Biophys Res Commun 155:740-746
93. Minamino N, Kangawa K, Matsuo H (1988b) Isolation and identification of a high molecular weight brain natriuretic peptide in porcine cardiac atrium. Biochem Biophys Res Commun 157:402-409
94. Misono KS, Fukumi H, Grammer RT et al (1984) Rat atrial natriuretic factor: complete amino acid sequence and disulfide linkage essential for biological activity. Biochem Biophys Res Commun 119:524-529
95. Mohammed SF, Korinek J, Chen HH et al (2008) Nesiritide in acute decompensated heart failure: current status and future perspectives. Rev Cardiovasc Med 9:151-158
96. Mukoyama M, Nakao K, Saito Y et al (1990a) Human brain natriuretic peptide, a novel cardiac hormone. Lancet 335:801-802
97. Mukoyama M, Nakao K, Saito Y et al (1990b) Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 323:757-758
98. Mukoyama M, Nakao K, Hosoda K et al (1991) Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87:1402-1412
99. Nicolau N, Butur G, Laky D (1997) Electronmicroscopic observations regarding the presence of natriuretic granules in the ventricle of patients with cardiopathies. Rom J Morphol Embryol 43:119-137
100. Nielsen SJ, Goetze JP, Jensen H et al (2008) ProCNP and CNP are primarily expressed in male genital organs. Regul Pept 146:204-212
101. Patterson SW, Starling EH (1914) On the mechanical factors which determine the output of the ventricles. J Physiol 48:357-379
102. Pemberton CJ, Johnson ML, Yandle TG et al (2000) Deconvolution analysis of cardiac natriuretic peptides during acute volume overload. Hypertension 36:355-359
103. Prigge ST, Mains RE, Eipper BA et al (2000) New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell Mol Life Sci 57:1236-1259
104. Rehfeld JF, Goetze JP (2003) The posttranslational phase of gene expression: new possibilities in molecular diagnosis. Curr Mol Med 3:25-38
105. Rehfeld JF, Bundgaard JR, Goetze JP et al (2004) Naming progastrin-derived peptides. Regul Pept 120:177-183
106. Richards AM, Crozier IG, Holmes SJ et al (1993) Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension. J Hypertens 11:163-170
107. Rubattu S, Sciarretta S, Valenti V et al (2008) Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. Am J Hypertens 21:733-741
108. Ruskoaho H (2003) Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 24:341-356
109. Saito Y, Nakao K, Itoh H et al (1989) Brain natriuretic peptide is a novel cardiac hormone. Biochem Biophys Res Commun 158:360-368
110. Sawada Y, Inoue M, Kanda T et al (1997a) Co-elevation of brain natriuretic peptide and proproteinprocessing endoprotease furin after myocardial infarction in rats. FEBS Lett 400:177-182
111. Sawada Y, Suda M, Yokoyama H et al (1997b) Stretch-induced hypertrophic growth of cardiocytes and processing of brain-type natriuretic peptide are controlled by proprotein-processing endoprotease furin. J Biol Chem 272:20545-20554
112. Schellenberger U, O'Rear J, Guzzetta A et al (2006) The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Arch Biochem Biophys 451:160-166
113. Schulz S (2005) C-type natriuretic peptide and guanylyl cyclase B receptor. Peptides 26:1024-1034
114. Schulz H, Langvik TA, Lund SE et al (2001) Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma. Scand J Clin Lab Invest 61:33-42
115. Seferian KR, Tamm NN, Semenov AG et al (2007) The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure. Clin Chem 53:866-873
116. Seferian KR, Tamm NN, Semenov AG et al (2008) Immunodetection of glycosylated NT-proBNP circulating in human blood. Clin Chem 54:866-873
117. Seidler T, Pemberton C, Yandle T et al (1999) The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs. Biochem Biophys Res Commun 255:495-501
118. Severino A, Campioni M, Straino S et al (2007) Identification of protein disulfide isomerase as a cardiomyocyte survival factor in ischemic cardiomyopathy. J Am Coll Cardiol 50:1029-1037
119. Shimizu H, Masuta K, Aono K et al (2002) Molecular forms of human brain natriuretic peptide in plasma. Clin Chim Acta 316:129-135
120. Shimizu H, Masuta K, Asada H et al (2003) Characterization of molecular forms of probrain natriuretic peptide in human plasma. Clin Chim Acta 334:233-239
121. Smith MW, Espiner EA, Yandle TG et al (2000) Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase. J Endocrinol 167:239-246
122. Steiner DF (2004) The proinsulin C-peptide - a multirole model. Exp Diabesity Res 5:7-14
123. Steiner HJ, Weiler R, Ludescher C et al (1990) Chromogranins A and B are co-localized with atrial natriuretic peptides in secretory granules of rat heart. J Histochem Cytochem 38:845-850
124. Steinhelper ME (1993) Structure, expression, and genomic mapping of the mouse natriuretic peptide type-B gene. Circ Res 72:984-992
125. Stoffers DA, Green CB, Eipper BA (1989) Alternative mRNA splicing generates multiple forms of peptidyl-glycine alpha-amidating monooxygenase in rat atrium. Proc Natl Acad Sci USA 86:735-739
126. Sudoh T, Kangawa K, Minamino N et al (1988) A new natriuretic peptide in porcine brain. Nature 332:78-81
127. Sudoh T, Maekawa K, Kojima M et al (1989) Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun 159:1427-1434
128. Sudoh T, Minamino N, Kangawa K et al (1990) C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 168:863-870
129. Takemura G, Takatsu Y, Doyama K et al (1998) Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J Am Coll Cardiol 31:754-765
130. Tamura N, Ogawa Y, Chusho H et al (2000) Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA 97:4239-4244
131. Taupenot L, Harper KL, O'Connor DT (2003) The chromogranin-secretogranin family. N Engl J Med 348:1134-1149
132. Thuerauf DJ, Glembotski CC (1997) Differential effects of protein kinase C, Ras, and Raf-1 kinase on the induction of the cardiac B-type natriuretic peptide gene through a critical promoter-proximal M-CAT element. J Biol Chem 272:7464-7472
133. Topol EJ (2005) Nesiritide - not verified. N Engl J Med 353:113-116
134. Tota B, Angelone T, Mazza R et al (2008) The chromogranin A-derived vasostatins: new players in the endocrine heart. Curr Med Chem 15:1444-1451
135. Tse MY, Watson JD, Sarda IR et al (2001) Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice. Mol Cell Biochem 219:99-105
136. Tsuruda T, Boerrigter G, Huntley BK et al (2002) Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 91:1127-1134
137. Underwood R, Chiravuri M, Lee H et al (1999) Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase. J Biol Chem 274:34053-34058
138. Vanhoof G, Goossens F, De Meester I et al (1995) Proline motifs in peptides and their biological processing. FASEB J 9:736-744
139. Wang TJ, Larson MG, Levy D et al (2003) Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation 108:13-16
140. Wang W, Liao X, Fukuda K et al (2008) Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity. Circ Res 103:502-508
141. Weidemann A, Klanke B, Wagner M et al (2008) Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction. Biochem J 409:233-242
142. Wu Q (2007) The serine protease corin in cardiovascular biology and disease. Front Biosci 12:4179-4190
143. Wu F, Yan W, Pan J et al (2002) Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes. J Biol Chem 277:16900-16905
144. Wu C, Wu F, Pan J et al (2003) Furin-mediated processing of Pro-C-type natriuretic peptide. J Biol Chem 278:25847-25852
145. Yan W, Sheng N, Seto M et al (1999) Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem 274:14926-14935
146. Yan W, Wu F, Morser J et al (2000) Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. Proc Natl Acad Sci U S A 97:8525-8529
147. Yang-Feng TL, Floyd-Smith G, Nemer M et al (1985) The pronatriodilatin gene is located on the distal short arm of human chromosome 1 and on mouse chromosome 4. Am J Hum Genet 37:1117-1128
148. Yokota N, Bruneau BG, Fernandez BE et al (1995) Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats. Am J Hypertens 8:301-310